Kwality Pharmaceuticals has received approval from Brazil's National Health Surveillance Agency ANVISA (Agencia Nacional de Vigilancia Sanitaria) for its Injectable formulations manufacturing unit at Amritsar along with Oncology Injectable unit at Himachal Pradesh.
The approval grants access to the Company to register and market its products at the large and growing Brazilian Pharmaceutical Market. The ANVISA approved facility is capable to manufacture liquid injection (in form of Ampoule and vials) and lyophilized formulation (vials).
Kwality Pharmaceuticals (formerly Kwality Pharmaceuticals) is a pharmaceutical formation company. It is engaged in manufacturing finished pharmaceutical formulations in dosage form.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1862.15 |
| Dr. Reddys Labs. | 1350.00 |
| Cipla | 1440.30 |
| Zydus Lifesciences | 1101.50 |
| Lupin | 2342.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: